HR Director Research Results 2019

Findings from Criticaleye's HRD Retreat Research:

  • Influencing the Board is where HRDs feel they fall short
  • 48% of HRDs say leadership teams need to improve the quality of debate around strategy
  • Limited exposure is the no.1 barrier to HRDs influencing the Board
  • 87% of HRDs are facing business model disruption
  • Only 24% of HRDs are fully confident the executive team has the ability to execute on strategy
  • Retaining talent and developing skills are the top priority for HRDs over the next 12 month
Click here to watch Roanne Parry, VP HR, Emerging Markets & Classic and Established Products, GlaxoSmithKline; Paul Pomroy, CEO, McDonald’s UK; Gerard Jacques, Director of People, Eurostar International and Julie Harding, Criticaleye Board Mentor talk about the role of HR in strategy.  
 




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Inside The Take Private at Pr...

After a whirlwind journey from the NYSE to private ownership, PropertyGuru CFO Joe Dische reflects on making the hard calls. In this interview with Criticaleye Senior Editor Bridgette Hall, he discusses public vs privat...

Inspiring Leaders Podcast: Le...

Rob Hornby, Co-CEO of AlixPartners and Rita Clifton CBE, Portfolio Chair and Non-Executive Director (including Deputy Chair of the John Lewis Partnership, Chair of Simplyhealth, Chair of the international sustainability...

Inspiring Leaders Podcast: De...

Lucinda Charles-Jones, Non-executive Director & Chair or RemCo for Virgin Money and Rank Group (plus a Criticaleye Board Mentor) and Jim Devine, Group HRD, Spirax Group speak to us about some of the findings of our ...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 483




Google Rolls-Royce Workday Concentrix Accenture E.ON UK IBM Consulting AlixPartners Drax Group plc Worldpay NATS Palo Alto Networks Aldermore Group British Land Salesforce Eightfold AI NatWest Group Hitachi Solutions FTSE Women Leaders Review Lightsource bp Legal & General London Stock Exchange Group GlaxoSmithKline plc